We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-13.07%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$330B
AUM Growth
-$62B
Cap. Flow
-$3.19B
Cap. Flow %
-0.97%
Top 10 Hldgs %
11.32%
Holding
4,260
New
250
Increased
2,115
Reduced
1,487
Closed
228

Top Buys

Rank Stock Value
1
HEI.A icon
HEICO Corp Class A
HEI.A
+$966M
2
VZ icon
Verizon
VZ
+$445M
3
XOM icon
ExxonMobil
XOM
+$409M
4
COR icon
Cencora
COR
+$269M
5
ZTO icon
ZTO Express
ZTO
+$266M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$341M
2
AVTR icon
Avantor
AVTR
+$318M
3
CDK
CDK Global, Inc.
CDK
+$253M
4
CRM icon
Salesforce
CRM
+$249M
5
HCA icon
HCA Healthcare
HCA
+$242M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Healthcare 13.37%
3 Financials 12.68%
4 Industrials 10.6%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIP
3676
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$38.1M
$146K ﹤0.01%
5,744
+2,983
+108% +$168K
ACB
3677
Aurora Cannabis
ACB
$173M
$145K ﹤0.01%
10,941
+1,213
+12% +$30.4K
GCMG icon
3678
GCM Grosvenor
GCMG
$754M
$145K ﹤0.01%
21,214
+6,063
+40% +$49.4K
IBRX icon
3679
ImmunityBio
IBRX
$7.51B
$145K ﹤0.01%
39,052
+3,344
+9% +$13.4K
ROVR
3680
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$144K ﹤0.01%
+38,134
New +$196K
AERI
3681
DELISTED
Aerie Pharmaceuticals
AERI
$143K ﹤0.01%
19,077
-268
-1% -$1.89K
BRCC icon
3682
BRC Inc
BRCC
$121M
$142K ﹤0.01%
+17,470
New +$240K
DSGN icon
3683
Design Therapeutics
DSGN
$761M
$142K ﹤0.01%
+10,137
New +$137K
FEAM icon
3684
5E Advanced Materials
FEAM
$45.7M
$142K ﹤0.01%
+506
New +$263K
KPTI icon
3685
Karyopharm Therapeutics
KPTI
$43.5M
$141K ﹤0.01%
2,073
-30
-1% -$2.75K
ULCC icon
3686
Frontier Group Holdings
ULCC
$1.55B
$141K ﹤0.01%
14,926
-337
-2% -$3.41K
ESPR
3687
DELISTED
Esperion Therapeutics
ESPR
$140K ﹤0.01%
21,906
+7,801
+55% +$44.2K
FEO
3688
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$138K ﹤0.01%
15,641
-419
-3% -$3.92K
CBH
3689
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$137K ﹤0.01%
15,940
-23,321
-59% -$211K
MRSN
3690
DELISTED
Mersana Therapeutics
MRSN
$135K ﹤0.01%
1,168
-35
-3% -$3.29K
AFMD
3691
DELISTED
Affimed
AFMD
$134K ﹤0.01%
4,822
+491
+11% +$16.8K
SVM
3692
Silvercorp Metals
SVM
$2.07B
$134K ﹤0.01%
54,247
+4,269
+9% +$12.9K
SWIM icon
3693
Latham Group
SWIM
$629M
$134K ﹤0.01%
19,222
+1,302
+7% +$13.8K
CRDO icon
3694
Credo Technology Group
CRDO
$38.6B
$133K ﹤0.01%
11,348
-82,161
-88% -$955K
KZR
3695
DELISTED
Kezar Life Sciences
KZR
$133K ﹤0.01%
1,614
-39,100
-96% -$3.45M
LQDA icon
3696
Liquidia Corp
LQDA
$7.48B
$133K ﹤0.01%
30,415
-227,307
-88% -$1.17M
HYFM icon
3697
Hydrofarm Holdings
HYFM
$2.57M
$132K ﹤0.01%
3,807
+402
+12% +$32.7K
MDXG icon
3698
MiMedx Group
MDXG
$602M
$132K ﹤0.01%
38,096
-3,887
-9% -$15.2K
PFO
3699
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$120M
$132K ﹤0.01%
+13,842
New +$140K
MVST icon
3700
Microvast
MVST
$269M
$131K ﹤0.01%
+58,572
New +$252K

Similar funds

Invesco's Q2 2022 Portfolio in Review

As of Q2 2022, Invesco held 4,260 positions worth $330B, down 16% from $392B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Invesco's Q2 2022 filing shows 250 new, 2,115 increased, 1,487 reduced and 228 closed positions. Its largest new stake was Heliogen, Inc.: 258,718 shares worth $19.1M. The largest sale was Qualcomm, an estimated $341M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2022 buy was Heliogen, Inc.: 258,718 shares worth $19.1M.
  • Invesco added most to HEICO Corp Class A in Q2 2022, an estimated $966M increase.
  • Invesco's biggest Q2 2022 reduction was Qualcomm, cutting an estimated $341M.
  • Invesco fully exited Cerner Corp in Q2 2022, selling an estimated $153M.
  • Invesco's ten largest holdings make up 11% of its $330B portfolio in Q2 2022.
  • Invesco opened 250 new positions and closed 228 in Q2 2022.
  • Invesco's portfolio value fell 16% quarter-over-quarter to $330B.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.